Home Page Overall Ranking ROE Ranking P/E Ranking Dividend Yield Capitalization Our eBook Our Book Contact










Isin CH0012005267
Ticker NVS
Company NOVARTIS
Currency $
Price
Aware Investor Index (AII) 2.7011
Recommendation BUY
P/E 20.14
ROE 12.87 %
Capitalization 203,928,000,000 $
Dividend Yield 3.30 %
P/S 3.93
AII Position 192
P/E Position 276
ROE Position 281
Capitalization Position 45
Dividend Yield Position 215
Sales 51,900,000,000 $
10-Year Average Earnings 10,125,900,000 $
Shares Outstanding 2,344,000,000
Equity 78,692,000,000 $
Dividend per Share 2.87 $
Industry Pharmaceutical
Country Switzerland
NOVARTIS Investor Relations Web Site http://www.novartis.com/investors/index.shtml







Sales:

YEAR MONTH AMOUNT
2018 12 51,900,000,000.00 $
2017 12 49,109,000,000.00 $
2016 12 48,518,000,000.00 $
2015 12 49,414,000,000.00 $
2014 12 52,180,000,000.00 $
2013 12 51,869,000,000.00 $

Earnings:

YEAR MONTH AMOUNT
2018 12 12,614,000,000.00 $
2017 12 7,703,000,000.00 $
2016 12 6,698,000,000.00 $
2015 12 17,794,000,000.00 $
2014 12 10,280,000,000.00 $
2013 12 9,292,000,000.00 $
2012 12 9,383,000,000.00 $
2011 12 9,072,000,000.00 $
2010 12 9,969,000,000.00 $
2009 12 8,454,000,000.00 $

Equity:

YEAR MONTH AMOUNT
2018 12 78,692,000,000.00 $
2017 12 74,227,000,000.00 $
2016 12 74,891,000,000.00 $
2015 12 77,122,000,000.00 $
2014 12 70,884,000,000.00 $
2013 12 74,472,000,000.00 $
2012 12 69,219,000,000.00 $
2011 12 65,940,000,000.00 $

Shares Outstanding:

YEAR MONTH AMOUNT
2018 12 2,344,000,000
2017 12 2,371,000,000
2016 12 2,400,000,000
2015 12 2,438,000,000
2014 12 2,470,000,000
2013 12 2,479,000,000
2012 12 2,418,145,330
2011 12 2,406,700,000

 












Bloomberg News for NOVARTIS:



Google News for NOVARTIS:



Back